Has Andrew Turk, MD received payments from drug or device companies?

Yes. Drug and device makers reported $35,442 in general payments to Andrew Turk, MD across 31 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Andrew Turk, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Andrew Turk, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Andrew Turk, MD

Anatomic Pathology & Clinical Pathology · New York, NYNPI 1043479991

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $22,420 of the $35,442 with a category attached, or 63.3%. Bayer accounts for 79.0% of it on its own, with 4 other manufacturers making up the rest. Reporting peaked in 2019 at $23,904 and has fallen 99.9% since, to $26 in 2025. Among anatomic pathology & clinical pathology clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$35,442in general payments, 2019–2025

Across 31 payments — averaging $1143.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Bayer$28K
Roche Diagnostics Corporation$7K
Tepha Inc$163
AbbVie$119
Merck$26

What the payments were for

Consulting fees$10,23029%
Speaking & faculty fees$22,42063%
Travel & lodging$2,2226%
Food & beverage$5452%
Education$260%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Bayer	26	$28,014
Roche Diagnostics Corporation	2	$7,120
Tepha Inc	1	$163
AbbVie	1	$119
Merck	1	$26

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Vitrakvi$21,027
BenchMark ULTRA$3,560
GalaFLEX$163
NATRELLE SALINE-FILLED BREAST IMPLANTS$119

How this compares

$35,442 in reported general payments places this provider in the 95th percentile of 468 anatomic pathology & clinical pathology providers in New York.

See all anatomic pathology & clinical pathology providers in New York →

Medicare billing

Part B allowed, 2024

$68,861

Medicare patients

384

Services billed

1,534

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other anatomic pathology & clinical pathology in New York

Adebowale AdeniranNew York$106K
Leal HerlitzNew York$92K
Shabnam JafferNew York$69K
Hannah WenNew York$60K
Soo Ryum YangNew York$60K
Mary BeasleyNew York$50K
Maria FielNew York$42K
Maria ArcilaNew York$42K
Sarah ChiangNew York$33K
Thomas BauerNew York$17K

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →